Michael Erb
@michael-erb.bsky.social
📤 573
📥 230
📝 20
Chemical Biologist at The Scripps Research Institute
reposted by
Michael Erb
Craig M. Crews
about 2 months ago
www.biorxiv.org/content/10.1...
loading . . .
Rewiring DNA repair with PARP-based chemical inducers of proximity
Chemical inducers of proximity (CIPs) can elicit durable, and often neomorphic, biological effects through the formation of a ternary complex, even at low equilibrium occupancy of their targets. This ...
https://www.biorxiv.org/content/10.1101/2025.07.26.666954v1
0
9
2
New work out today introducing PCIPs, heterobifunctional chemical inducers of proximity that inhibit DNA repair by recruiting BET proteins to PARP2. Great work uncovering a new form of event-driven pharmacology by Bryce/Eric/Erin and the rest of the team. (1/3)
www.biorxiv.org/content/10.1...
loading . . .
Rewiring DNA repair with PARP-based chemical inducers of proximity
Chemical inducers of proximity (CIPs) can elicit durable, and often neomorphic, biological effects through the formation of a ternary complex, even at low equilibrium occupancy of their targets. This ...
https://www.biorxiv.org/content/10.1101/2025.07.26.666954v1
about 2 months ago
1
18
4
reposted by
Michael Erb
Rita Strack
3 months ago
At the Bioorganic GRC. Ahmed Bedram just gave a very cool talk on genetic code expansion with quadruplet codons. Check out some of the work here
www.nature.com/articles/s41...
loading . . .
Efficient genetic code expansion without host genome modifications - Nature Biotechnology
Noncanonical amino acids are efficiently incorporated into proteins by optimizing mRNA codon usage.
https://www.nature.com/articles/s41587-024-02385-y
0
9
2
On my way to
#aacr25
. I’ll be chairing Part 3 of “Chemistry to the Clinic” tomorrow (4/26 at 2:30) with talks from
@dannomura.bsky.social
and
@xiaoyuzhang.bsky.social
. Weather report calls for lots of chemoproteomics, molecular glues, and tough targets. Please join us!
5 months ago
1
19
2
reposted by
Michael Erb
Jordan Meier
6 months ago
Great news: NIH postbac program is recruiting again! If your grad school plans were affected by program cutbacks or admissions freezes this year I highly encourage you to apply, this could be a perfect opportunity. Please repost.
www.training.nih.gov/research-tra...
loading . . .
https://www.training.nih.gov/research-training/pb/pb/
5
211
199
reposted by
Michael Erb
Giordano Lippi
6 months ago
Delighted to see our paper finally out in
@cp-neuron.bsky.social
! Together with Ian MacRae, we developed a new toolbox to study microRNAs and used it to find new mechanisms of Purkinje cell development. Please see the tweetorial from researcher extraordinaire
@norjin.bsky.social
for details.
add a skeleton here at some point
3
20
4
reposted by
Michael Erb
ACS BIOL: Division of Biochemistry and Chemical Biology
6 months ago
Congratulations to Prof. Brian Liau, recipient of this year's Eli Lilly Award in Biological Chemistry, and to the excellent presenters who made up this morning's award symposium!
@michael-erb.bsky.social
, Jesus Gutierrez,
@brianliau.bsky.social
, Yuh Min Chook,
@xiaoyuzhang.bsky.social
#ACSSpring2025
0
19
1
excited to celebrate Brian's Eli Lilly award tomorrow and to talk all things molecular glues!
add a skeleton here at some point
6 months ago
0
3
0
reposted by
Michael Erb
Chris Parker
6 months ago
Happy to share a new preprint from our group in collaboration with AbbVie led by graduate student
@inesforrest.bsky.social
www.biorxiv.org/content/10.1...
loading . . .
Proteome-Wide Discovery of Degradable Proteins Using Bifunctional Molecules
Targeted protein degradation (TPD) is an emergent therapeutic strategy with the potential to circumvent challenges associated with targets unamenable to conventional pharmacological inhibition. Among ...
https://www.biorxiv.org/content/10.1101/2025.03.21.644652v1
2
24
6
reposted by
Michael Erb
Jordan Meier
6 months ago
At his last celebration, he said something that stayed with me: "When you start, you think science is about the papers...then you realize it's about the people."
1
10
3
reposted by
Michael Erb
Georg Winter
6 months ago
Something that qualifies as big news from my side: I am very happy and excited to announce that I have been appointed as Life Science Director at AITHYRA, a new Research Institute for Biomedical Artificial Intelligence. Find out more in the link and 🧵 below
lnkd.in/d_HaGuSE
loading . . .
LinkedIn
This link will take you to a page that’s not on LinkedIn
https://lnkd.in/d_HaGuSE
3
106
15
reposted by
Michael Erb
Jonathan Rosenblum
7 months ago
Make Thalidomide-for-morning-sickness Great Again
add a skeleton here at some point
0
5
2
reposted by
Michael Erb
ChemKritzer
7 months ago
🚨 Chemical Biology & Probes study section (formerly SBCB, one of two NIH panels that reviews chemistry
#chemsky
🧪) was abruptly POSTPONED w/no specific plans for rescheduling, less than 24h before start. If this affects you call your reps & senators, talk to local news, make your voice heard 📢 👩🔬
4
35
32
Congrats Brian and team. Such an elegant discovery. Small molecules can do it all!
add a skeleton here at some point
7 months ago
1
2
0
check out this beautiful science from Xiaoyu, it'll cure your NIH blues for a few minutes
add a skeleton here at some point
8 months ago
1
8
0
reposted by
Michael Erb
Vijay G. Sankaran
8 months ago
While on clinical service recently, I saw many children who were severely ill due to cancer, flu, and other causes. Sadly this move will mean that healthcare access for many children will be lost, as our institutions suffer from the loss of this critical support:
grants.nih.gov/grants/guide...
loading . . .
NOT-OD-25-068: Supplemental Guidance to the 2024 NIH Grants Policy Statement: Indirect Cost Rates
NIH Funding Opportunities and Notices in the NIH Guide for Grants and Contracts: Supplemental Guidance to the 2024 NIH Grants Policy Statement: Indirect Cost Rates NOT-OD-25-068. OD
https://grants.nih.gov/grants/guide/notice-files/NOT-OD-25-068.html
0
36
8
Not more dramatic than MJ
add a skeleton here at some point
8 months ago
0
3
0
Thanks for chairing a great session Katherine, really enjoyed it!
add a skeleton here at some point
10 months ago
0
3
0
reposted by
Michael Erb
Carolyn Bertozzi
10 months ago
Maybe a good time to plug this awesome book edited by former PhD students Howard Hang (Scripps), Matt Pratt (USC), Jenn Prescher (UC Irvine), featuring chapters by leaders in the field including
@jeremybaskin.bsky.social
and a forward by yours truly.
add a skeleton here at some point
0
67
11
reposted by
Michael Erb
Michael Gilman
10 months ago
They disrupt nuclear aggregate formation in patient cells, correct relevant splicing defects, and fully reverse myotonia in mice. And they do all this while preserving the things we know and love about small molecules, including broad biodistribution and oral bioavailability.
1
6
2
reposted by
Michael Erb
Alexis Verger 🧬🧫🧪
10 months ago
Saturation mutagenesis CRISPR screen to map CREs of PD-L1 + TFs CRISPR LoF screen to identify known & novel trans-regulators + CUT&RUN to confirm new regulators + HiChIP enhancers/promoters contact maps Very impressive work by
@nevillesanjana.bsky.social
www.biorxiv.org/content/10.1...
loading . . .
Paired CRISPR screens to map gene regulation in cis and trans
Recent massively-parallel approaches to decipher gene regulatory circuits have focused on the discovery of either cis -regulatory elements (CREs) or trans -acting factors. Here, we develop a scalable ...
https://www.biorxiv.org/content/10.1101/2024.11.27.625752v1
1
15
4
reposted by
Michael Erb
Dan Nomura
10 months ago
Cool paper from Fleur Ferguson’s lab:
onlinelibrary.wiley.com/doi/abs/10.1...
loading . . .
A Kinetic Scout Approach Accelerates Targeted Protein Degrader Development
Bifunctional molecules such as targeted protein degraders induce proximity to promote gain-of-function pharmacology. These powerful approaches have gained broad traction across academia and the pharm...
https://onlinelibrary.wiley.com/doi/abs/10.1002/anie.202417272
0
17
1
reposted by
Michael Erb
Georg Winter
10 months ago
Dual-ligase PROTACs: a novel approach for enhancing TPD. By recruiting two distinct E3 ligases within a single molecule, we amplify degradation efficacy & potentially mitigate resistance occurrence. Great collabo with the Ciulli lab & friends at Promega.
pubs.acs.org/doi/10.1021/...
loading . . .
Leveraging Dual-Ligase Recruitment to Enhance Protein Degradation via a Heterotrivalent Proteolysis Targeting Chimera
Proteolysis targeting chimera (PROTAC) degraders are typically bifunctional with one E3 ligase ligand connected to one target protein ligand via a linker. While augmented valency has been shown with trivalent PROTACs targeting two binding sites within a given target protein, or used to recruit two different targets, the possibility of recruiting two different E3 ligases within the same compound has not been demonstrated. Here we present dual-ligase recruitment as a strategy to enhance targeted protein degradation. We designed heterotrivalent PROTACs composed of CRBN, VHL and BET targeting ligands, separately tethered via a branched trifunctional linker. Structure–activity relationships of 12 analogues qualifies AB3067 as the most potent and fastest degrader of BET proteins, with minimal E3 ligase cross-degradation. Comparative kinetic analyses in wild-type and ligase single and double knockout cell lines revealed that protein ubiquitination and degradation induced by AB3067 was contributed to by both CRBN and VHL in an additive fashion. We further expand the scope of the dual-ligase approach by developing a heterotrivalent CRBN/VHL-based BromoTag degrader and a tetravalent PROTAC comprising of two BET ligand moieties. In summary, we provide proof-of-concept for dual-E3 ligase recruitment as a strategy to boost degradation fitness by recruiting two E3 ligases with a single degrader molecule. This approach could potentially delay the outset of resistance mechanisms involving loss of E3 ligase functionality.
https://pubs.acs.org/doi/10.1021/jacs.4c11556
1
47
11
reposted by
Michael Erb
Fleur Ferguson
10 months ago
Excited to share our work investigating how ligand residence time influences targeted protein degradation outcomes at scale, and how we can combine kinetic scout degrader approaches with mathematical modeling to accelerate hit finding and optimization!
onlinelibrary.wiley.com/doi/abs/10.1...
loading . . .
A Kinetic Scout Approach Accelerates Targeted Protein Degrader Development
Bifunctional molecules such as targeted protein degraders induce proximity to promote gain-of-function pharmacology. These powerful approaches have gained broad traction across academia and the pharm....
https://onlinelibrary.wiley.com/doi/abs/10.1002/anie.202417272
2
44
9
you reached the end!!
feeds!
log in